Page last updated: 2024-11-12
retinol oleate
Description
retinol oleate: RN given refers to (Z)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
all-trans-retinyl oleate : A fatty acid ester formed between oleic acid and all-trans-retinol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 11699609 |
CHEBI ID | 70760 |
SCHEMBL ID | 15375758 |
MeSH ID | M0124459 |
Synonyms (25)
Synonym |
all-trans-retinyl oleate |
retinol oleate |
retinol 15-[(9z)-9-octadecenoate |
vitamin a oleate |
631-88-9 |
retinol, 9-octadecenoate, (z)- |
8hu01dh65p , |
retinyl oleate |
unii-8hu01dh65p |
CHEBI:70760 |
all-trans-retinyl 9z-octadecenoate |
o(15)-[(9z)-octadec-9-enoyl]retinol |
(2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl (9z)-octadec-9-enoate |
retinol, (z)-9-octadecenoate |
o-oleoyl-all-trans-retinol |
oleic acid, ester with retinol |
retinyl oleate [inci] |
retinol, (9z)-9-octadecenoate |
retinol, 15-((9z)-9-octadecenoate) |
SCHEMBL15375758 |
LMFA07011033 |
Q27139070 |
vae 18:1 |
[(2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (z)-octadec-9-enoate |
DTXSID601021962 |
Drug Classes (1)
Class | Description |
fatty acid ester | A carboxylic ester in which the carboxylic acid component can be any fatty acid. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (14)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 5 (35.71) | 18.7374 |
1990's | 4 (28.57) | 18.2507 |
2000's | 3 (21.43) | 29.6817 |
2010's | 2 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.56
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 11.56 (24.57) | Research Supply Index | 2.77 (2.92) | Research Growth Index | 4.33 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 15 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |